![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh8bCi1e0GE275Fsz2pYbj6hcD3UAxpErLgFikwiX-wkLVsJ-N7PBatvORT0Qtxqcdpth3Y88V69QtdqIjPe6PTWgTqwuoKQsquVn_WllplPkDyBTmR8gwHn_PvcETvvQu9h0xbNQ/s200/hart.gif)
Monday, October 06, 2008
BioMimetic Chief Science Officer resigns
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh8bCi1e0GE275Fsz2pYbj6hcD3UAxpErLgFikwiX-wkLVsJ-N7PBatvORT0Qtxqcdpth3Y88V69QtdqIjPe6PTWgTqwuoKQsquVn_WllplPkDyBTmR8gwHn_PvcETvvQu9h0xbNQ/s200/hart.gif)
Labels:
BioMimetic Therapeutics,
biotechnology,
Charles Hart
Subscribe to:
Post Comments (Atom)
Exploring innovation, investment and technologies
in Nashville, Tennessee, United States.
Please visit our website: VentureNashville.com
No comments:
Post a Comment